2018 ACC/AHA Guideline

• Lipid/Biomarkers: Associated with increased ASCVD risk

-Persistently* elevated, Primary hypertriglycerdemia (>=175mg/dl)

-if measured:

• High-sensitivity C-reactive protein-(>=2.0mg/L)
• Elvated lipoprotein(a)-A relative indication for its measurement is family history of premature ASCVD. An Lp(a)>=50mg/dL or >=125nmol/L constitutes a risk enhancing factor especially at higher levels of Lp(a)
• Elevated aop B>=130 mg/dL-A relative indiction for its measurement would be triglyceride>=200mg/dL. A level >=130mg/dl corresponds to an LDL-C>=160 mg/dL and constitures a risk enhancing factor.
• ABI<0.9